Document Detail

A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review.
MedLine Citation:
PMID:  20490588     Owner:  NLM     Status:  In-Process    
This report seeks to describe the clinical efficacy and safety of infliximab in a patient with psoriatic arthritis on hemodialysis and to review the literature on the topic. We present a patient with psoriatic arthritis on hemodialysis treated with infliximab and we review the literature. Our case includes a patient with severe psoriasis and dactylitis with chronic renal failure requiring regular hemodialysis. At presentation the patient had a psoriasis area and severity index (PASI) score of 35.1 and dactylitis affecting the right thumb. Evaluation of laboratory parameters revealed a slight increase of erythrocyte sedimentation rate (21 mm/h) and a mild normocytic anemia (Hct 36.4). The rest of the laboratory and imaging tests were within normal limits. Infliximab was initiated at the loading dose of 5 mg/kg body weight at weeks 0, 2, 6, and every 8 weeks thereafter. On retreatment at week 14 the PASI score was measured to 3.4. After the conclusion of 6 months of treatment, the reduction of PASI score was sustained reaching the point of 0.8. In addition, dactylitis, as well as laboratory parameters, showed a striking improvement. On the other hand, during the same period of time, no changes of renal functions were noted and no complications were reported and the patient continued his hemodialysis on a regular basis. Our case is in accordance with other reports supporting that infliximab treatment in patients undergoing hemodialysis can be safe, well tolerated, and effective. However, larger trials are needed to prove its use in these patients.
Ioanna Saougou; Charalampos Papagoras; Theodora E Markatseli; Paraskevi V Voulgari; Alexandros A Drosos
Related Documents :
2265898 - Serial epilepsy caused by levodopa/carbidopa administration in two patients on hemodial...
11955988 - Blink reflex in end-stage-renal disease patients undergoing hemodialysis.
2597458 - Reasonably short hemodialysis time can be achieved without ultra-high efficiency dialyz...
17044478 - Anemia and survival in thai hemodialysis patients: evidence from national registry data.
20923678 - Type of cftr mutation determines risk of pancreatitis in patients with cystic fibrosis.
15192318 - Magical ideation -- defense mechanism or neuropathology? a study with multiple sclerosi...
Publication Detail:
Type:  Journal Article     Date:  2010-05-21
Journal Detail:
Title:  Clinical rheumatology     Volume:  29     ISSN:  1434-9949     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1455-9     Citation Subset:  IM    
Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Perineal hernia repair with acellular dermal graft and suture anchor fixation.
Next Document:  Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephrit...